Relevance of laboratory investigations in monitoring patients with psoriasis on etanercept or adalimumab. [electronic resource]
Producer: 20111017Description: 375-82 p. digitalISSN:- 1365-2133
- Adalimumab
- Adult
- Anti-Inflammatory Agents, Non-Steroidal -- adverse effects
- Antibodies, Antinuclear -- metabolism
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- C-Reactive Protein -- metabolism
- Clinical Laboratory Techniques -- statistics & numerical data
- Drug Monitoring -- methods
- Etanercept
- Female
- Humans
- Immunoglobulin G -- adverse effects
- Male
- Middle Aged
- Prospective Studies
- Psoriasis -- drug therapy
- Receptors, Tumor Necrosis Factor
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.